Gendevra

Description

Gendevra is a potent combination antiviral drug for the systemic treatment of human immunodeficiency virus-1 (HIV-1) carriers who are not resistant to the integrase blocking class of drugs, emtricitabine or tenofovir. The drug Gendevra does not eliminate HIV viruses, but it significantly reduces their number in the blood and, accordingly, reduces the likelihood of developing AIDS.

Active ingredients:  elvitegravir, cobicistat, emtricitabine, tenofovir

Prescription medicine